Last update 23 Jan 2025

Allogeneic anti-CD19 CAR-T (Tianjin First Center Hospital)

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms-
Target
CD19
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors)
Therapeutic Areas
Immune System DiseasesHemic and Lymphatic Diseases
Active Indication
B-Cell Malignant Neoplasm
Inactive Indication-
Originator Organization
Tianjin First Center HospitalTianjin First Center Hospital
Active Organization
Tianjin First Center HospitalTianjin First Center Hospital
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with Allogeneic anti-CD19 CAR-T (Tianjin First Center Hospital)
ChiCTR1800020064
/ RecruitingPhase 1/2IIT
A single-center, single-arm, open-label, dose escalation study for evaluating the safety & preliminary anti-tumor activity of CD19 allogeneic chimeric antigen receptor T cells (CD19 Allo-CAR-T) in the treatment of patients with relapsed / refractory B cell malignancies
ChiCTR1800015164
/ SuspendedNot ApplicableIIT
multi-center clinical study of CD19+ -car-t cells combined with chemotherapy in the treatment of the newly diagnosed high-risk adult PH (-) B-ALL
ChiCTR1800019288
/ RecruitingEarly Phase 1IIT
A clinical trial for safety and efficient of CD19CART cells combination with nivolumab in the treatment of refractory/relapsed B cell lymphoma
100 Clinical Results associated with Allogeneic anti-CD19 CAR-T (Tianjin First Center Hospital)
Login to view more data
100 Translational Medicine associated with Allogeneic anti-CD19 CAR-T (Tianjin First Center Hospital)
Login to view more data
100 Patents (Medical) associated with Allogeneic anti-CD19 CAR-T (Tianjin First Center Hospital)
Login to view more data
100 Deals associated with Allogeneic anti-CD19 CAR-T (Tianjin First Center Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
B-Cell Malignant NeoplasmPhase 1-
Tianjin First Center HospitalTianjin First Center Hospital
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free